Sanofi, Regeneron halve the price of new cancer treatment Zaltrap
Filed under: drug treatment news
The colorectal cancer drug isn't an overstock, but a brand-new product, approved by FDA in August. Like most new cancer drugs these days, it's expensive, with a price tag of about $ 9,600 per month for a typical patient. Unlike other pricey cancer …
Read more on FiercePharma
Two Type 2 Diabetes Drugs Compared, How Did They Do?
Filed under: drug treatment news
If you have type 2 diabetes, there are many drug treatment options at your disposal, and the numbers continue to grow. Two of the newer type 2 diabetes drugs, exenatide (Bydureon) and liraglutide (Victoza) were recently compared in a head-to-head study …
Read more on eMaxHealth
For Biotech Investors: 5 Orphan Drugs And Their Parent Companies
Filed under: drug treatment news
Drugs that treat rare diseases generally cost a lot more as well, which means that orphan drugs can be extremely high-margin sources of income. Here are promising orphan drugs and their parent companies that have garnered a lot of interest from …
Read more on Seeking Alpha